Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data

Low-dose computed tomography screening can be used to diagnose lung cancer at a younger age compared to no screening. Real-world studies observing mortality after lung cancer diagnosis are subject to lead-time bias. This study developed a method using a nationwide cancer registry and stage shift fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Szu-Chun, Wang, Jung-Der, Wang, Shi-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190256/
https://www.ncbi.nlm.nih.gov/pubmed/34108586
http://dx.doi.org/10.1038/s41598-021-91852-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190256/
https://www.ncbi.nlm.nih.gov/pubmed/34108586
http://dx.doi.org/10.1038/s41598-021-91852-6

Ejemplares similares